Clinical Trial Search

Primary: Changes in Patient Reported Pain and Discomfort — 47; 13; -30; -18 percent change from baseline

Primary: Brief Pain Inventory - Pain Interference — -23; -22 units on a scale — p=0.90

Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83

Primary: Composite Pain Severity — 5.6; 5.6 score on a scale

Primary: Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 12 — -11.6; -6.0 Morphine Milligram Equivalents (MME) — p=0.31

Primary: Percent Change in Average Daily Pain Score — 38.6; 30.0; 20.6 percent change — p=0.01

Primary: Pain Intensity — 11; 29 Participants

Primary: Pain Intensity Score Measures — 55; 57 Score on a scale

Primary: Assessment of Opioid Use Via Subject Report — 47.5; 21.75 morphine milligram equivalent

Primary: Pain Interference Subscale of Brief Pain Inventory (BPI) — 4.7; 4.8; 4.9; 4.4 score on a scale

Primary: Number of Participants Reporting Adverse Events — 138; 151; 110; 62 Participants

Primary: Change in Visual Analog Scale (VAS) Score From Baseline to 2 Week Post Initial Fitting. — 35 participants with > 50% VAS improvement

Primary: Feasibility - Study Retention — 0.96 Proportion of participants

Primary: Brief Pain Inventory Score — 8; 6.7 score on a scale

Primary: Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS") — 6.485; 6.645; 5.486; 6.210 score on a scale

Primary: Adjusted Change in Pain-related Function (Roland Disability Score) — -1.4; -0.2 units on a scale

Primary: Pain Ratings — 3.60; 4.69; 4.83; 5.41 units on a scale — p=.05

Primary: Change in Pain Interference — -3.82; .32 T-score

Primary: Brief Pain Inventory-Intensity (BPI-Intensity) — 6.19; 5.42; 5.68; 5.95 units on a scale — p=.165

Primary: Change in the Brief Pain Inventory (BPI) Interference Score From Baseline, Over the 12-month Follow-up Period. — 4.8; 4.5; 5.2 score on a scale — p=0.031

Primary: Patient 's Change From Baseline of Pain Severity as Measured by the Weekly Means of the Daily Average Pain Scores (APS) During 4 Weeks of Treatment — 0.87; 0.5 units on…

Primary: Brief Pain Inventory — 4.5; 5.1 units on a scale — p=.27

Primary: Mean of the Change in Morphine Dosage (in mg) Required to Achieve 25% Reduction in Thermal Evoked Pain Responses Relative to Baseline (Pre-intervention) Placebo…

Primary: Brief Pain Inventory (BPI) Total Pain Severity — 6.1; 5.7; 5.8 score on a scale

Primary: Insomnia Severity — 6.0; 12.8; 4.4; 13.0 units on a scale — p=0.010

Primary: Brief Pain Inventory Interference Scale — 3.7; 3.7; 3.4; 3.6 units on a scale

Primary: Analgesia — 36.3; 71.8 units on a VAS scale — p=0.097

Primary: Change in Pain Intensity — -0.7; -0.8 score on a scale — p=0.5913

Primary: Low Back Pain Intensity — 1.24; 1.73 units on a scale

Primary: Change in Pain Interference — -0.9; 0.2 units on a scale